Michael Gelband’s Northrim BanCorp NRIM Stock Holding History

Michael Gelband’s Portfolio NRIM Stock Details NRIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,082	Closed	-$299K	–	1913
2026 Q1	$299K	Buy	+13,082	New	+$325K	﹤0.01%	1312

Other funds holding NRIM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DLP

De Lisle Partners Poole, United Kingdom $916M AUM 54.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Michael Gelband's NRIM Position: Q2 2026 in Review

Michael Gelband sold out of Northrim BanCorp (NRIM) in Q2 2026, closing a stake of 13,082 shares — an estimated $299K sold.

Michael Gelband first reported a position in NRIM in Q1 2026 and held it in 1 quarter. The position peaked at $299K in Q1 2026. 155 funds tracked by Wall St. Rank hold NRIM as of Q2 2026.

Michael Gelband reported no remaining Northrim BanCorp position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 13,082 Northrim BanCorp shares in Q2 2026, an estimated $299K.
Michael Gelband first reported a position in Northrim BanCorp in Q1 2026 and held it in 1 quarter.
Michael Gelband's Northrim BanCorp position peaked at $299K in Q1 2026.
155 funds tracked by Wall St. Rank held Northrim BanCorp as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.